A study evaluating predictive role of perfusion-computed tomography scan parameters for improved outcomes in patients with hepatocellular carcinoma treated with Sorafenib.
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer; Liver cirrhosis
- Focus Therapeutic Use
- 10 Jul 2017 New trial record